RBM5: A Promising Drug Target / Biomarker (G10181)

Target Name: RBM5

NCBI ID: G10181

RBM5

RBM5: A Promising Drug Target / Biomarker

RBM5 (receptor-bound microRNA) is a protein that is expressed in various tissues and cells in the body. It is a non-coding RNA molecule that plays a crucial role in regulating gene expression, and it is considered as a potential drug target or biomarker. RBM5 is composed of 294 amino acids and has a calculated molecular weight of 3.1 kDa. It is expressed in various tissues, including brain, heart, liver, and muscle. RBM5 has been shown to play a role in several biological processes, including cell growth, apoptosis, and inflammation.

Drug Target Potential
RBM5 is a potential drug target due to its unique structure and its involvement in various biological processes. Its unique structure, which consists of a long extracellular domain and a short intracellular domain, makes it a potential protein that can be targeted by small molecules. Additionally, RBM5 is involved in multiple cellular processes that are crucial for human health, making it an attractive target for drug development.

One of the potential mechanisms by which RBM5 can be targeted is through its role in cell apoptosis. RBM5 has been shown to play a role in the regulation of cell apoptosis, which is a natural process that helps remove damaged or dysfunctional cells from the body. Studies have shown that RBM5 can induce cell apoptosis in various cell types, including cancer cells. Additionally, RBM5 has been shown to play a role in the regulation of cell cycle progression, which is a critical process that helps cells divide and grow.

Another potential mechanism by which RBM5 can be targeted is through its role in inflammation. RBM5 has been shown to play a role in the regulation of inflammatory responses, which are critical for maintaining tissue health and responding to injuries or infections. Studies have shown that RBM5 can regulate the production of pro-inflammatory cytokines, such as TNF-alpha, which are involved in inflammation.

Biomarker Potential
RBM5 has also been shown to have potential as a biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Studies have shown that RBM5 levels can be affected by various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, RBM5 levels have been shown to be elevated in various types of cancer, including breast, lung, and ovarian cancer. Additionally, RBM5 levels have been shown to be elevated in individuals with neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

Conclusion
In conclusion, RBM5 is a protein that has potential as a drug target or biomarker. Its unique structure and involvement in various biological processes make it an attractive target for small molecules. Additionally, its potential as a biomarker for several diseases makes it a promising tool for the development of new therapies. Further research is needed to fully understand the role of RBM5 in various biological processes and to develop effective treatments.

Protein Name: RNA Binding Motif Protein 5

Functions: Component of the spliceosome A complex. Regulates alternative splicing of a number of mRNAs. May modulate splice site pairing after recruitment of the U1 and U2 snRNPs to the 5' and 3' splice sites of the intron. May both positively and negatively regulate apoptosis by regulating the alternative splicing of several genes involved in this process, including FAS and CASP2/caspase-2. In the case of FAS, promotes exclusion of exon 6 thereby producing a soluble form of FAS that inhibits apoptosis. In the case of CASP2/caspase-2, promotes exclusion of exon 9 thereby producing a catalytically active form of CASP2/Caspase-2 that induces apoptosis

The "RBM5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RBM5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets